Combining Imaging and Endovascular Therapy into the CLI Clinical Algorithm: Live Case Presentation from AMP 2019
Combining Imaging and Endovascular Therapy into the CLI Clinical Algorithm: Live Case Presentation from AMP 2019
Live Case Operator:
Fadi Saab, MD
Chief Operations Officer
Advanced Cardiac & Vascular Centers for Amputation Prevention
Grand Rapids, Michigan
Moderator:
Jihad Mustapha, MD
Co-founder and CEO
Advanced Cardiac & Vascular Centers for Amputation Prevention
Grand Rapids, Michigan
Panelists:
George Adams, MD
Interventional Cardiology Director Cardiovascular and Peripheral Vascular Research
UNC REX Healthcare
University of North Carolina Chapel Hill Medical Center
Raleigh, North Carolina
Marianne Brodmann, MD
Substitute Head of Division of Angiology
Medical University Graz
Graz, Austria
Bryan Fisher, MD
Chief of Vascular Surgery
Centennial Medical Center
Nashville, Tennessee
Craig Walker, MD
Clinical Professor of Medicine
Tulane Medical School Cardiovascular Institute of the South
Houma, Louisiana
Provided by North American Center for Continuing Medical Education, LLC, an HMP Company.
For questions regarding this educational activity, please call 609-371-1137 or email info@naccme.com.
This activity is designed for interventional cardiologists, vascular surgeons, interventional radiologists, wound care specialists, podiatrists, nurses, vascular technologists, and cardiovascular catheterization laboratory team members.
This on-demand webcast is available with video and audio.
In order to be eligible for documentation of credit, participants must attend the full webcast, complete the post-test with a score of 75% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.
Release Date: September 30, 2019
Reaccredited: September 30, 2021
Expiration Date: September 30, 2022
Estimated time to complete: 1 hour
There is no fee associated with this activity.
For questions regarding this educational activity, please call 609-371-1137.
In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
NACCME designates this internet enduring activity for a maximum of 1 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing nursing education internet enduring activity awards 1.0 contact hour.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.
NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 1.00 AAPA Category 1 credit.
PAs should only claim credit commensurate with the extent of their participation.
NACCME is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine.
NACCME has approved this internet enduring activity for a maximum of 1.0 continuing education contact hour.
Combining Imaging and Endovascular Therapy into the CLI Clinical Algorithm: Live Case Presentation from AMP 2019 taking place from September 30, 2021 to September 30, 2022 has been approved for 1.0 A+ ARRT CE credits by the Association for Vascular and Interventional Radiographers (AVIR). The AVIR is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).
This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.
This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.
The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.
The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
Clinical Reviewer:
Jos C. van den Berg
Ospedale Regionale di Lugano sede Civico University of Bern
Lugano, Switzerland
Planning Committee
The planning committee comprises Fadi Saab, MD; Jihad Mustapha, MD; Marianne Brodmann, MD; George Adams, MD; Bryan Fisher, MD; Craig Walker, MD; and MaryEllen Fama, Caitlin Eastman, Jennifer Ilcyn, Colleen Waters, and Chris Bolwell, NACCME.
The faculty has reported the following:
Dr. Saab: Consultant - BD Bard, Boston Scientific, Cardiovascular Systems, Inc, Gore, Medtronic, Philips, Terumo; Grant/Research Support - Boston Scientific, CardioFlow, PQ Bypass
Dr. Mustapha: Consultant - BD Bard, Boston Scientific, Cardiovascular Systems, Inc., Medtronic, Philips, Terumo, PQ Bypass; Grant/Research Support - Boston Scientific, CardioFlow, PQ Bypass; Major Stock Shareholder - CardioFlow
Dr. Adams: Consultant - Abbott Vascular, Asahi Intecc, Bard, Boston Scientific, Cardinal Health, Cardiovascular Systems Inc., Control Medical, Cook Medical, CloSys, Daiichi Sankyo, Gore, Intact Vascular, Lake Region Medical, Marine Polymer Technologies, Medtronic, Mercator Med-Systems, Meril, Penumbra, Philips, Shockwave Medical, Soundbite, Surmodics, Terumo; Grant/ Research Support - Abbott Vascular, Bard, Boston Scientific, Cardiovascular Systems Inc., Cook Medical, CloSys, Daiichi Sankyo, Gore, Intact Vascular, Lake Region Medical, Marine Polymer Technologies, Medtronic, Mercator Med-Systems, Penumbra, Philips, Shockwave Medical, Soundbite, Surmodics; Speakers’ Bureau - Abbott Vascular, Asahi Intecc, Cardiovascular Systems Inc., Control Medical, Cook Medical, Gore, Intact Vascular, Lake Region Medical, Marine Polymer Technologies, Medtronic, Mercator Med-Systems, Penumbra, Philips, Shockwave Medical, Soundbite
Dr. Brodmann: Consultant – Intact Vascular, Medtronic, BD Bard, Philips Spectranetics, Cagent; Speakers’ Bureau – Intact Vascular, Medtronic, BD Bard, Philips Spectranetics, Cagent, Daiichi Sankyo, Bayer Healthcare
Dr. Fisher: Consultant – Philips, Abbott, Cordis, Cook; Speakers’ Bureau – Cordis
Dr. Walker: Speaker’s Bureau – Philips/Volcano, Amgen, Janssen Pharmaceuticals
Ms. Fama, Ms. Eastman, Ms. Ilcyn, Ms. Waters, and Mr. Bolwell have disclosed no relevant financial relationships with any commercial interests.
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.
North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2021 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.
This activity is supported by an educational grant from Philips IGT.
